ArticleCancer letters2019

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.

Albert A De Vera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.